Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02739893 · ClinicalTrials.gov registry record · NA
Usefulness of A Scope Guide Assisted Colonoscopy Versus Conventional Colonoscopy
A NA study of Colonoscopy, Colorectal, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT02739893 is a NA study of Colonoscopy, Colorectal that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 300 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02739893, a NA study of Colonoscopy, Colorectal, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to see if use of ScopeGuide, as compared to the traditional colonoscope, improves successful completion of colonoscopy procedures as evaluated by ease of completion, time to completion, and reduction in the number of mechanical loops and external maneuvers required to advance the scope. Other outcome measures include looking at the amount of sedation required (independent of weight) and polyp rate detection.
Conditions Studied
Interventions
- PROCEDURE Scope Guide Assist
- PROCEDURE Standard procedure for colonoscopy
Study Locations (1)
Alabama
- University of Alabama - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2016-01 |
| Est. Completion | 2019-02-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02739893
The ClinicalTrials.gov registry entry for NCT02739893 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colonoscopy, Colorectal appearing as the primary indexed condition, and to 2 interventions - of which Scope Guide Assist is the first listed.
NCT02739893 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT02739893 about?
NCT02739893 is a clinical study titled "Usefulness of A Scope Guide Assisted Colonoscopy Versus Conventional Colonoscopy". The aim of this study is to see if use of ScopeGuide, as compared to the traditional colonoscope, improves successful completion of colonoscopy procedures as evaluated by ease of completion, time to completion, and reduction in the number of mechanical loops and external maneuvers required to advanc...
What is the current status of trial NCT02739893?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2016-01. Estimated completion is 2019-02-07.
What conditions does trial NCT02739893 study?
This clinical trial studies the following conditions: Colonoscopy, Colorectal.
What interventions are being tested in trial NCT02739893?
The interventions under investigation include: Scope Guide Assist (PROCEDURE), Standard procedure for colonoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT02739893?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02739893 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.